top of page

South Africa SAHPRA's Med Dev Guidance: Updated Q&A-Guide to Licensing Medical Device Establishments

In South Africa, the licensing of medical device establishments is a vital step to ensure compliance with national health regulations and to guarantee the safety and performance of medical devices in the market. To assist manufacturers, importers, distributors, and wholesalers, the South African Health Products Regulatory Authority (SAHPRA) has released an updated guideline on Questions and Answers: Licensing of Medical Device Establishments (Version 4, May 2025).


This detailed and user-friendly document provides clarity on the submission process, renewal applications, required documentation, applicable fees, and key operational expectations for all stakeholders in the medical device supply chain. In this blog, we summarise and interpret the key sections of this guideline, offering a practical and comprehensive overview for industry professionals.


The guideline is designed to supplement SAHPRA's core licensing documentation, answering frequently asked questions from applicants. It aims to improve the efficiency and clarity of the licensing process and applies to manufacturers, distributors, and wholesalers of medical devices and in vitro diagnostics (IVDs).


There are three main types of medical device establishment licences:

  • Manufacturer’s Licence (GLF-MD-06A): Required for those involved in manufacturing, packaging, labeling, servicing, or refurbishing medical devices. This licence also covers import, distribution, and export activities.

  • Wholesaler’s Licence (GLF-MD-06B): For establishments procuring devices from local sources and selling to retailers. This licence does not permit import or export.

  • Distributor’s Licence (GLF-MD-06C): For importers, exporters, or distributors. Third-party storage providers must also be licensed.


Renewal applications must be submitted at least 90 days before expiry and follow similar documentation requirements to new applications.

Renewals cannot include major amendments, such as a change of company name or activities. If renewal is attempted less than six weeks before expiry or after the licence expires, a new application is required.


Submission Process and Documentation

The application process is digital and begins on the SAHPRA website. Applicants must:

  • Download the relevant application form in Microsoft Excel format.

  • Submit a cover letter on company letterhead, signed by the authorised representative, addressed to the CEO, and listing all annexures.

  • Include supporting documents such as:

    • The completed application form (Excel and signed PDF)

    • Curriculum Vitae of the authorised representative

    • Quality Manual (for manufacturers/distributors) or Site Master File (for wholesalers)

    • Proof of payment for the application fee

    • ISO 13485 certification (for COVID-19-related products)

  • Ensure all documents are initialed and signed as required

Applications involving COVID-19-related products (e.g., PPE, test kits, ventilators) require additional documentation, including ISO 13485 certification. Business-as-usual applications pertain to all other medical devices and follow standard requirements.


A Quality Manual is mandatory for manufacturers and distributors, detailing the quality management system, personnel, facilities, and procedures. Wholesalers must submit a Site Master File outlining their operational controls. The guideline references the official fee schedule available on the SAHPRA website. Licences must be renewed periodically, with a separate process and documentation requirements for renewals and amendments.


By following the outlined procedures, manufacturers, distributors, and wholesalers can confidently navigate the regulatory landscape, reduce delays, and ensure seamless access to the market.

📄 Download the Full Guideline (Version 4, May 2025):

I Sometimes Send Newsletters

Thanks for submitting!

  • LinkedIn
  • Facebook
  • Twitter
  • Instagram

DISCLAIMER

The views expressed in this publication do not necessarily reflect the views of any guidance of government, health authority, it's purely my understanding. This Blog/Web Site is made available by a regulatory professional, is for educational purposes only as well as to give you general information and a general understanding of the pharmaceutical regulations, and not to provide specific regulatory advice. By using this blog site you understand that there is no client relationship between you and the Blog/Web Site publisher. The Blog/Web Site should not be used as a substitute for competent pharma regulatory advice and you should discuss from an authenticated regulatory professional in your state.  We have made every reasonable effort to present accurate information on our website; however, we are not responsible for any of the results you experience while visiting our website and request to use official websites.

bottom of page